close

Fenwick & West Adds Prominent IP Litigation Partner in Seattle

Fenwick & West continues expansion of Seattle office with addition of prominent IP Litigator David K. Tellekson

March 1, 2010 (Seattle, WA) – Fenwick & West LLP, a leading technology and life sciences law firm with offices in Seattle, Silicon Valley and San Francisco, is pleased to announce today that prominent Seattle-based patent litigation lawyer David K. Tellekson has joined the firm and will lead the intellectual property litigation practice in its Seattle office.

Fenwick Chairman Gordon K. Davidson stated, "We are especially pleased that David will be joining Fenwick & West. David is an experienced lawyer who has deep life sciences expertise, a national litigation practice and substantial trial experience. He has handled a wide variety of complex matters involving complicated technologies. He has an excellent reputation in the legal community and possesses the rare qualities of being practical, results-oriented and able to distill complex legal issues down to practical advice to achieve business objectives."

Mr. Tellekson has represented clients in patent disputes in biotechnology, pharmaceuticals, polymer chemistry, medical devices, industrial chemistry and a wide variety of other technologies.

"Fenwick & West is a perfect fit for my practice," commented Tellekson. "The opportunity to become part of a firm that is nationally known for its powerful technology and life sciences platform, excellent legal services and collegial culture is compelling. Fenwick has a strong and expanding Seattle presence and a national litigation practice with first-tier litigators. I am excited to join Fenwick, and I believe we offer the blend of deep legal expertise and practical advice that clients are looking for."

Stephen Graham, who heads Fenwick's office in Seattle, stated, "David is a prominent senior litigator, with phenomenal credentials in the life sciences space, further solidifying our leadership position in that industry segment. He is an exceptional addition to our Seattle practice."

Litigation Chair Darryl Woo said, "We are very pleased to add a litigator of David's stature and trial acumen to our premier litigation practice. Adding David confirms our commitment to first-rate client service and exceptional legal capability."

Mr. Tellekson received his B.S. in Biochemistry from the University of Wisconsin in 1979, and his J. D. from DePaul University in 1983. Mr. Tellekson is a frequent writer and lecturer in areas of patent law and patent litigation, including:

  • The Intersection of Antitrust and Intellectual Property: A Review of Recent Case Law and Trends, Patent, Trademark & Copyright Journal (with John LaBarre),
  • Strategies for Attacking and Defending Pharmaceutical Patents; A Modern Take on 'The Art of War' Intellectual Property & Technology Law (with Sandra S. Lee and Elizabeth Richardson),
  • Litigation Issues/Trends in Licensing/Case Law Update, WSBA-CLE Seminar Look Before You License: Valuation, Negotiation, and More

Mr. Tellekson is admitted to practice before the U.S. Court of Appeals and the Federal Circuit Court. He is registered to practice before the U.S. Patent & Trademark office. He is a member of the state bar associations in Washington, New York, Illinois and Minnesota. He is also a Master Member of the Seattle Intellectual Property American Inn of Court.

Prior to joining Fenwick & West, Mr. Tellekson was the managing principal at Darby & Darby in Seattle. Mr. Tellekson has worked with prominent life sciences clients, including Novozymes, Cardiac Science, Oxford Biomedica, Glenmark Pharmaceuticals and 3M. He has also worked with Seattle technology clients including Widevine Technologies and National Products.


Fenwick & West

Established in 1972, Fenwick & West LLP is one of the nation's premier law firms providing comprehensive legal services to high technology and life sciences clients in Seattle, San Francisco and Silicon Valley; particularly in the areas of litigation and dispute resolution, antitrust, securities, venture capital and other corporate finance, corporate governance, joint ventures, M&A and strategic relationships, intellectual property, taxation and employment and labor law. More information can be found on www.fenwick.com.

Press Contacts:

Stephen Graham
Co-Chair, Life Sciences Group; Partner, Corporate Group
206.389.4520
sgraham@fenwick.com

Gordon Davidson
Chairman; Partner, Corporate Group
650.335.7237
gdavidson@fenwick.com

Kate Fritz
Partner, Litigation Group
415.875.2328
kfritz@fenwick.com